ACCP collaborates with ASHP on Ambulatory Care Pharmacy activities.
Series Overview
2020 ACCP/ASHP BCACP Clinical Sessions have been approved by the Board of Pharmacy Specialties for recertification of Board Certified Ambulatory Care Pharmacists (BCACPs). The sessions are jointly sponsored by ACCP and the American Society of Health-System Pharmacists.
This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants’ skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.
Release date: December 16, 2020
BCACP credit expiration date: December 14, 2021
ACPE credit expiration date: October 28, 2023
Program Content
The 2020 BCACP Clinical Sessions are offered in four presentations. Each presentation focuses on a different Ambulatory Care topic that is highly relevant for day-to-day practice. Topics include menopause, secondary stroke prevention, mild cognitive impairment, and obesity strategies.
Faculty
Managing Menopause: A “Hot” Topic
|
Lalita Prasad-Reddy, Pharm.D., M.S., BCPS, BCACP, CDE
Associate Professor of Pharmacy Practice
Chicago State University College of Pharmacy
Clinical Pharmacy Specialist
Rush University Medical Center
Chicago, Illinois |
|
Not So FAST: Engaging in SLOW Decision Making for Secondary Stroke Prevention
|
Pamela L. Stamm, Pharm.D., FASHP, BCPS, BCACP, CDE
Associate Professor of Pharmacy Practice
Harrison School of Pharmacy
Auburn University
Auburn, Alabama |
|
|
Mark Huffmyer, Pharm.D., BCACP, BCGP, CACP
Assistant Professor
Department of Pharmacy Practice & Science
University of Kentucky College of Pharmacy
Lexington, Kentucky |
|
An Unforgettable Session: The Pharmacist’s Role in Mild Cognitive Impairment
|
Gina Ayers, Pharm.D.
Clinical Pharmacy Specialist
Cleveland Clinic
Cleveland, Ohio |
|
|
Noll L. Campbell, Pharm.D., BCPP, BCGP
Assistant Professor for Pharmacy Practice
Purdue University
Indianapolis, Indiana |
|
|
Kristin Zimmerman, Pharm.D., BCGP
Associate Professor
Department of Pharmacotherapy and Outcomes Science
Virginia Commonwealth University School of Pharmacy
Richmond, Virginia |
|
The Weight of the World: Obesity Strategies and Controversies
|
Jennifer N. Clements, Pharm.D., FCCP, BCPS, CDE, BCACP
Clinical Pharmacist in Diabetes Transition
Spartanburg Regional Healthcare System
Spartanburg, South Carolina |
|
|
Diana Isaacs, Pharm.D., BCPS, BCACP
Clinical Pharmacy Specialist
Endocrinology & Metabolism Institute
Diabetes Center
Cleveland Clinic
Cleveland, Ohio |
|
Target Audience and Learning Objectives
Target Audience: Board Certified Ambulatory Care Pharmacists (BCACPs) and those interested in menopause, secondary stroke prevention, mild cognitive impairment, and obesity.
Learning Objectives:
At the conclusion of Managing Menopause: A “Hot” Topic the participant should be able to:
- Describe the spectrum of symptoms present in a perimenopausal female.
- Analyze the risk/benefit ratio of hormonal therapy for the management of perimenopausal symptoms.
- Recommend therapeutic regimens for the management of perimenopausal vasomotor symptoms.
- Select therapies for the management of postmenopausal osteoporosis taking into account guideline recommendations from the National Osteoporosis Foundation, The North American Menopause Society, and The Endocrine Society.
At the conclusion of Not So FAST: Engaging in SLOW Decision Making for Secondary Stroke Prevention the participant should be able to:
- Evaluate literature that defines secondary stroke treatment goals, including prevention, to the care of older adults.
- Identify clinical situations for secondary stroke prevention where life expectancy, functional status, patient preference or goals of care should override standard recommendations for screening/ treatment.
- Recommend secondary stroke prevention strategies for older adult patients with multiple conditions, including: hypertension, dyslipidemia, atrial fibrillation, tobacco use disorder, diabetes, and hormone deficiency.
At the conclusion of An Unforgettable Session: The Pharmacist’s Role in Mild Cognitive Impairment the participant should be able to:
- Demonstrate appropriate use of a screening tool for cognitive impairment.
- Determine potential reversible causes of cognitive impairment, including potentially inappropriate medication use in this population.
- Develop evidence-based and patient-centered treatment plans for older adults with mild cognitive impairment.
At the conclusion of The Weight of the World: Obesity Strategies and Controversies the participant should be able to:
- Develop patient-specific weight-loss goals.
- Evaluate the risk-benefit of non-pharmacological, pharmacological, and surgical options for weight management.
- Design an individualized treatment plan for weight management, incorporating evidence-based guidelines and primary literature.
- Create a patient-specific counseling and monitoring plan, following a specific weight-loss intervention
Continuing Pharmacy Education Credit
The American Society of Health-System Pharmacists and American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
BCACP and BCGP Clinical Session
Managing Menopause: A “Hot” Topic
Activity Number: 0204-9999-20-320-H01-P
Contact Hours: 1.00
Activity Type: Application-Based Activity
BCACP and BCGP Clinical Session
Not So FAST: Engaging in SLOW Decision Making for Secondary Stroke Prevention
Activity Number: 0204-9999-20-319-H01-P
Contact Hours: 1.50
Activity Type: Application-Based Activity
BCACP and BCGP Clinical Session
An Unforgettable Session: The Pharmacist’s Role in Mild Cognitive Impairment
Activity Number: 0217-9999-20-121-H01-P
Contact Hours: 1.50
Activity Type: Application-Based Activity
BCACP Clinical Session
The Weight of the World: Obesity Strategies and Controversies
Activity Number: 0217-9999-20-122-H01-P
Contact Hours: 2.00
Activity Type: Application-Based Activity
Methods and CE Requirements
ACPE Continuing Pharmacy Education Credit
To be eligible to earn continuing pharmacy education credit, participants must purchase the product, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by October 28, 2023. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
National Association of Boards of Pharmacy - CPE Monitor Service
Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.
To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.
Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.
Recertification Credit
To be eligible to earn BCACP recertification credit, participants must purchase the recertification version of this course, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by December 14, 2021. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
The passing point to earn BCACP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCACP posttest deadline that meets this passing point will earn BCACP recertification credits. These credits will be assigned as of the date of test submission. For statements of recertification credit, visit www.bpsweb.org.
All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.
Questions regarding the number of hours required for BCACP recertification should be directed to BPS at (202) 946-5026 or www.bpsweb.org.
Technical Requirements
Commercial Support
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.
Fees
Specialty Recertification
Offers up to 6.0 continuing pharmacy education credits/recertification credits
Includes:
- streaming audio/slide synchronized presentations
- downloadable mp3 audio files
- downloadable mp4 video files
- downloadable/printable PDFs of presentation slides
- online posttest(s) for CPE/Recertification credit
- Recertification Credit Deadline: December 14, 2021
|
Price: $250.00 |
Member: $150.00 |
|
Please note that the posttest will not be available until December 16, 2020.